Gregory Campbell McDermott, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 13 | 2024 | 918 | 3.200 |
Why?
|
Arthritis, Rheumatoid | 17 | 2024 | 3763 | 2.910 |
Why?
|
Bronchiectasis | 3 | 2024 | 139 | 1.720 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 | 2022 | 225 | 1.180 |
Why?
|
Antirheumatic Agents | 3 | 2024 | 1372 | 1.020 |
Why?
|
Spondylarthritis | 1 | 2024 | 61 | 0.840 |
Why?
|
Spondylitis, Ankylosing | 1 | 2024 | 155 | 0.810 |
Why?
|
Drug Substitution | 1 | 2024 | 290 | 0.750 |
Why?
|
Uveitis | 1 | 2024 | 395 | 0.690 |
Why?
|
Rheumatic Diseases | 4 | 2024 | 649 | 0.570 |
Why?
|
Peroxidase | 1 | 2020 | 609 | 0.560 |
Why?
|
Autoimmunity | 1 | 2024 | 1356 | 0.530 |
Why?
|
Rheumatology | 4 | 2024 | 615 | 0.490 |
Why?
|
Autoantibodies | 2 | 2022 | 2116 | 0.490 |
Why?
|
Biological Products | 1 | 2024 | 914 | 0.470 |
Why?
|
Autoimmune Diseases | 4 | 2024 | 2244 | 0.400 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2472 | 0.340 |
Why?
|
Air Pollution | 1 | 2023 | 2359 | 0.320 |
Why?
|
Air Pollutants | 1 | 2023 | 2896 | 0.320 |
Why?
|
Mucin-5B | 2 | 2023 | 148 | 0.250 |
Why?
|
Lung Transplantation | 2 | 2024 | 1310 | 0.230 |
Why?
|
Dioxygenases | 1 | 2024 | 345 | 0.190 |
Why?
|
Spirometry | 1 | 2024 | 929 | 0.180 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 289 | 0.170 |
Why?
|
Back Pain | 1 | 2024 | 545 | 0.170 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 463 | 0.170 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 306 | 0.170 |
Why?
|
Thorax | 1 | 2022 | 555 | 0.170 |
Why?
|
Troponin T | 1 | 2024 | 780 | 0.160 |
Why?
|
Risk Factors | 9 | 2024 | 74213 | 0.160 |
Why?
|
Humans | 35 | 2024 | 761572 | 0.160 |
Why?
|
Glucocorticoids | 2 | 2024 | 2161 | 0.150 |
Why?
|
Disease Progression | 4 | 2024 | 13510 | 0.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 515 | 0.150 |
Why?
|
Demography | 1 | 2022 | 1648 | 0.140 |
Why?
|
Vital Capacity | 3 | 2024 | 971 | 0.140 |
Why?
|
Remission Induction | 1 | 2022 | 2397 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2057 | 0.120 |
Why?
|
Asthma | 2 | 2023 | 6234 | 0.120 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2014 | 35 | 0.110 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2015 | 332 | 0.110 |
Why?
|
Cell Dedifferentiation | 1 | 2014 | 122 | 0.110 |
Why?
|
Carcinosarcoma | 1 | 2014 | 106 | 0.110 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4740 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 346 | 0.100 |
Why?
|
Middle Aged | 11 | 2024 | 220920 | 0.100 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2024 | 3204 | 0.100 |
Why?
|
Promoter Regions, Genetic | 1 | 2022 | 5790 | 0.090 |
Why?
|
Scalp | 1 | 2014 | 389 | 0.090 |
Why?
|
Male | 16 | 2024 | 360842 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 487 | 0.090 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 517 | 0.090 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2015 | 478 | 0.090 |
Why?
|
Lung | 3 | 2023 | 10002 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2023 | 1703 | 0.090 |
Why?
|
Scleroderma, Systemic | 2 | 2024 | 344 | 0.090 |
Why?
|
Odds Ratio | 1 | 2022 | 9646 | 0.090 |
Why?
|
Life Style | 1 | 2022 | 3917 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2015 | 3639 | 0.090 |
Why?
|
Female | 15 | 2024 | 392686 | 0.090 |
Why?
|
Recurrence | 1 | 2022 | 8466 | 0.080 |
Why?
|
Prevalence | 2 | 2023 | 15732 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1054 | 0.080 |
Why?
|
Respiratory Function Tests | 2 | 2024 | 1682 | 0.080 |
Why?
|
Forced Expiratory Volume | 2 | 2024 | 1814 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 5 | 2023 | 17904 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2014 | 560 | 0.080 |
Why?
|
Logistic Models | 1 | 2022 | 13255 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2014 | 829 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2023 | 22176 | 0.070 |
Why?
|
Smoking | 1 | 2024 | 9053 | 0.070 |
Why?
|
Indoles | 1 | 2015 | 1833 | 0.070 |
Why?
|
Aged | 11 | 2024 | 169310 | 0.070 |
Why?
|
Melanoma | 2 | 2015 | 5709 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2015 | 1310 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1978 | 0.060 |
Why?
|
Mutation | 4 | 2024 | 30054 | 0.060 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2024 | 32 | 0.060 |
Why?
|
Prospective Studies | 3 | 2024 | 54426 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2014 | 2571 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2014 | 5821 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2822 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12690 | 0.060 |
Why?
|
Sarcoma | 1 | 2014 | 1801 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 29629 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9610 | 0.050 |
Why?
|
Sjogren's Syndrome | 1 | 2024 | 238 | 0.050 |
Why?
|
Societies, Medical | 2 | 2024 | 3905 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4513 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2024 | 80646 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3537 | 0.050 |
Why?
|
Myositis | 1 | 2024 | 271 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9758 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39107 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5305 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2895 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1435 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15501 | 0.040 |
Why?
|
Adult | 6 | 2024 | 221203 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4878 | 0.040 |
Why?
|
Mass Screening | 2 | 2024 | 5428 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1123 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1328 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7858 | 0.040 |
Why?
|
Tumor Stem Cell Assay | 1 | 2015 | 115 | 0.030 |
Why?
|
Phenotype | 3 | 2023 | 16592 | 0.030 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2014 | 67 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6935 | 0.030 |
Why?
|
Vinculin | 1 | 2014 | 59 | 0.030 |
Why?
|
Desmoplakins | 1 | 2014 | 61 | 0.030 |
Why?
|
Alcohol Oxidoreductases | 1 | 2014 | 169 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2015 | 670 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9031 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2014 | 4915 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3688 | 0.020 |
Why?
|
Biopsy | 2 | 2014 | 6766 | 0.020 |
Why?
|
Alleles | 1 | 2023 | 6864 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20571 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11076 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2015 | 858 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2014 | 2180 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1668 | 0.020 |
Why?
|
Genetic Variation | 2 | 2015 | 6567 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1835 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 12990 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3597 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14607 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1745 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 3968 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3778 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21355 | 0.020 |
Why?
|
United States | 2 | 2024 | 72335 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2020 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58986 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4111 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 22173 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4280 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6484 | 0.010 |
Why?
|
DNA Damage | 1 | 2014 | 2449 | 0.010 |
Why?
|
Models, Molecular | 1 | 2014 | 5439 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8321 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13446 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17635 | 0.010 |
Why?
|
Child | 2 | 2023 | 80156 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4425 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2014 | 4937 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14666 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5821 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2015 | 64684 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13642 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 42230 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81533 | 0.000 |
Why?
|
Young Adult | 1 | 2015 | 59255 | 0.000 |
Why?
|
Adolescent | 1 | 2015 | 88324 | 0.000 |
Why?
|
Animals | 1 | 2015 | 168467 | 0.000 |
Why?
|